(Portage) BIOD351 Module 3 - Final Test Readiness Exam Q & S 2024(Portage) BIOD351 Module 3 - Final Test Readiness Exam Q & S 2024(Portage) BIOD351 Module 3 - Final Test Readiness Exam Q & S 2024
, 1. Which of the following is a common side effect of ACE
inhibitors when used in patients with chronic kidney disease
(CKD)?
- A) Hyperkalemia
- B) Hypocalcemia
- C) Hypertension
- D) Bradycardia
- Correct Asnwer: A) Hyperkalemia
2. In managing atrial fibrillation, which class of drug is
commonly used to prevent stroke?
- A) Diuretics
- B) Anticoagulants
- C) Beta-blockers
- D) ACE inhibitors
- Correct Asnwer: B) Anticoagulants
3. Which drug is the first-line treatment for hypertension in
a patient with diabetic nephropathy?
- A) Thiazide diuretics
- B) Calcium channel blockers
- C) ACE inhibitors
- D) Beta-blockers
- Correct Asnwer: C) ACE inhibitors
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller NURSATI. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for $14.49. You're not tied to anything after your purchase.